Hypothesis

12 Matching Annotations

May 2026
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRAS G12D Inhibitor

1
1. scibot 05 May 2026
  
  in Public
  
  RRID:CVCL_1584
  
  DOI: 10.1158/2159-8290.CD-25-1346
  
  Resource: (KCLB Cat# 90727, RRID:CVCL_1584)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1584
  
  What is this?
  
  RRID:CVCL_1584
Visit annotations in context

Tags

RRID:CVCL_1584

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC13133609/
Jun 2025
www.sciencedirect.com www.sciencedirect.com

A first-in-class EGFR-directed KRAS G12V selective inhibitor

1
1. scibot 21 Jun 2025
  
  in Public
  
  RRID:CVCL_1584
  
  DOI: 10.1016/j.ccell.2025.05.016
  
  Resource: (KCLB Cat# 90727, RRID:CVCL_1584)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1584
  
  What is this?
  
  RRID:CVCL_1584
Visit annotations in context

Tags

RRID:CVCL_1584

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610825002259
cancer-nano.biomedcentral.com cancer-nano.biomedcentral.com

Exosomal encapsulation of a steviol derivative SD9 to overcome TRAIL resistance as a highly effective therapy against lung cancer

1
1. scibot 17 Jun 2025
  
  in Public
  
  RRID:CVCL_1584
  
  DOI: 10.1186/s12645-025-00329-y
  
  Resource: (KCLB Cat# 90727, RRID:CVCL_1584)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1584
  
  What is this?
  
  RRID:CVCL_1584
Visit annotations in context

Tags

RRID:CVCL_1584

Annotators

scibot

URL

cancer-nano.biomedcentral.com/articles/10.1186/s12645-025-00329-y
May 2025
www.sciencedirect.com www.sciencedirect.com

Generation of T cell responses against broad KRAS hotspot neoantigens for cell therapy or TCR discovery

1
1. scibot 17 May 2025
  
  in Public
  
  RRID:CVCL_1584
  
  DOI: 10.1016/j.crmeth.2025.101049
  
  Resource: (KCLB Cat# 90727, RRID:CVCL_1584)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1584
  
  What is this?
  
  RRID:CVCL_1584
Visit annotations in context

Tags

RRID:CVCL_1584

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2667237525000852
Jan 2025
52.53.155.43 52.53.155.43

1-s2.0-S2589004225001245-main-html.html

2
1. scibot 23 Jan 2025
  
  in Public
  
  RRID: CVCL_1584
  
  DOI: 10.1016/j.isci.2025.111864
  
  Resource: (KCLB Cat# 90727, RRID:CVCL_1584)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_1584
  
  What is this?
  
  RRID:CVCL_1584
2. scibot 23 Jan 2025
  
  in Public
  
  RRID:CVCL_1584
  
  DOI: 10.1016/j.isci.2025.111864
  
  Resource: (KCLB Cat# 90727, RRID:CVCL_1584)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1584
  
  What is this?
  
  RRID:CVCL_1584
Visit annotations in context

Tags

RRID:CVCL_1584

Annotators

scibot

URL

52.53.155.43/b8347d751839197edb20fe1168219b4048f4b01d/1-s2.0-S2589004225001245-main-html.html
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Improving PD-1 blockade plus chemotherapy for complete remission of lung cancer by nanoPDLIM2

1
1. scibot 04 Jan 2025
  
  in Public
  
  RRID:CVCL_1584
  
  DOI: 10.7554/eLife.89638
  
  Resource: (KCLB Cat# 90727, RRID:CVCL_1584)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1584
  
  What is this?
  
  RRID:CVCL_1584
Visit annotations in context

Tags

RRID:CVCL_1584

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC11668523/
Apr 2024
febs.onlinelibrary.wiley.com febs.onlinelibrary.wiley.com

DRD1 suppresses cell proliferation and reduces EGFR activation and PD-L1 expression in NSCLC

1
1. scibot 11 Apr 2024
  
  in Public
  
  RRID:CVCL_1584
  
  DOI: 10.1002/1878-0261.13608
  
  Resource: (KCLB Cat# 90727, RRID:CVCL_1584)
  
  Curator: @AniH
  
  SciCrunch record: RRID:CVCL_1584
  
  What is this?
  
  RRID:CVCL_1584
Visit annotations in context

Tags

RRID:CVCL_1584

Annotators

scibot

URL

febs.onlinelibrary.wiley.com/doi/full/10.1002/1878-0261.13608
Jan 2024
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

In situ modeling of acquired resistance to RTK/RAS pathway targeted therapies

1
1. scibot 18 Jan 2024
  
  in Public
  
  RRID:CVCL_1584
  
  DOI: 10.1016/j.isci.2023.108711
  
  Resource: (KCLB Cat# 90727, RRID:CVCL_1584)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1584
  
  What is this?
  
  RRID:CVCL_1584
Visit annotations in context

Tags

RRID:CVCL_1584

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10788224/
Mar 2023
febs.onlinelibrary.wiley.com febs.onlinelibrary.wiley.com

FEBS Press

1
1. scibot 17 Mar 2023
  
  in Public
  
  RRID:CVCL_1584
  
  DOI: 10.1002/1878-0261.13393
  
  Resource: (KCLB Cat# 90727, RRID:CVCL_1584)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1584
  
  What is this?
  
  RRID:CVCL_1584
Visit annotations in context

Tags

RRID:CVCL_1584

Annotators

scibot

URL

febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.13393
Jul 2022
www.sciencedirect.com www.sciencedirect.com

Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer

1
1. scibot 30 Jul 2022
  
  in Public
  
  ATCCNCI-H727
  
  DOI: 10.1016/j.celrep.2022.111066
  
  Resource: (KCLB Cat# 90727, RRID:CVCL_1584)
  
  Curator: @sophiastull
  
  SciCrunch record: RRID:CVCL_1584
  
  What is this?
  
  RRID:CVCL_1584
Visit annotations in context

Tags

RRID:CVCL_1584

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124722008646
Aug 2021
www.sciencedirect.com www.sciencedirect.com

RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer

1
1. scibot 01 Aug 2021
  
  in Public
  
  RRID:CVCL_1584
  
  DOI: 10.1016/j.chembiol.2019.12.005
  
  Resource: (KCLB Cat# 90727, RRID:CVCL_1584)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:CVCL_1584
  
  What is this?
  
  RRIDCUR:Validated RRID:CVCL_1584
Visit annotations in context

Tags

RRID:CVCL_1584

RRIDCUR:Validated

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2451945619304015